Xenotransplantation--how far have we come?

Area of Science:

• Immunology
• Transplantation Science
• Medical Research

Background:

• Xenotransplantation presents significant immunologic barriers hindering organ transplantation.
• Acute humoral xenograft rejection is a major obstacle, driven by antibody responses.
• Understanding these barriers is critical for advancing xenotransplantation strategies.

Purpose of the Study:

• To summarize the immunologic barriers in xenotransplantation.
• To review current approaches for overcoming xenograft rejection.
• To discuss the risks and incompatibilities associated with pig-to-human transplantation.

Main Methods:

• Review of existing literature on xenotransplantation immunology.
• Analysis of therapeutic strategies targeting antibody-mediated rejection.
• Discussion of tolerance induction and risk assessment.

Main Results:

• Acute humoral xenograft rejection is a primary challenge.
• Combination therapy (anti-CD154 and mycophenolate mofetil) may prevent induced antibody responses.
• Natural anti-Gal antibody deposition causes rejection and coagulopathy.

Conclusions:

• Managing natural antibody responses, particularly anti-Gal, is essential for xenotransplantation success.
• Further research into tolerance induction is needed.
• Addressing microbiologic and physiologic risks is vital for pig-to-human transplants.